Related Experiment Video

Updated: May 23, 2026

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

The Interface between Inflammation and Coagulation in Cardiovascular Disease

Gabriele Demetz1, Ilka Ott

  • 1Deutsches Herzzentrum Technische Universität München, Lazarettstraße 36, 80636 München, Germany.

International Journal of Inflammation
|April 21, 2012
PubMed

Insights

Coagulation and inflammation intimately connect in vascular disease. Understanding this interplay, particularly tissue factor and protease-activated receptors, is key to developing new cardiovascular disease treatments.

Area of Science:

  • Biomedical research
  • Cardiovascular science
  • Inflammation and coagulation pathways

Background:

  • The interplay between coagulation and inflammation is increasingly recognized in vascular disease pathogenesis.
  • Cardiovascular disease and acute coronary syndrome highlight this complex relationship.

Purpose of the Study:

  • To focus on the essential components of the coagulation-inflammation interplay.
  • To explore the roles of tissue factor and protease-activated receptors (PARs) in cardiovascular disease.

Main Methods:

  • Review of clinical research on coagulation and inflammation.
  • Focus on tissue factor as the initiator of the extrinsic coagulation pathway.
  • Examination of activated clotting factors (II, X, VII) and their interaction with protease-activated receptors.

Main Results:

  • Tissue factor initiates coagulation and elicits a proinflammatory response.
  • Protease-activated receptors (PARs) link coagulation factors to inflammatory signaling.
  • PAR-1 exhibits both detrimental and beneficial effects in this context.

Conclusions:

  • Unraveling the coagulation-inflammation nexus is crucial for understanding vascular disease.
  • Targeting these pathways may lead to novel therapeutic strategies for cardiovascular conditions.

More Related Videos

Visualizing Leukocyte Rolling and Adhesion in Angiotensin II-Infused Mice: Techniques and Pitfalls10:16

Visualizing Leukocyte Rolling and Adhesion in Angiotensin II-Infused Mice: Techniques and Pitfalls

Published on: January 4, 2018

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice11:18

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Published on: April 2, 2013

Related Concept Videos

Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Inflammation01:38

Inflammation

Overview
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation01:06

Coagulation

Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...